Moderna claims that NO ONE who got the vaccine in the trial developed severe COVID-19

Yesterday, the American biotechnology company Moderna announced the final results of the efficacy trial data of 30,000 volunteers- including high-risk groups like the healthcare providers and elderly- for its vaccine candidate in a press release.15,000 people received the actual vaccine while the other participants got placebo injections. No serious side effects were reported.

Only 11 people who received two doses of the vaccine developed COVID-19 symptoms after being infected with the pandemic coronavirus, versus 185 symptomatic cases in a placebo group., exceeding even the expectations of scientists conducting the trial.such COVID-19 cases among those vaccinated, but 30 in the placebo group. This is perhaps even more pleasantly surprising development.

It must be noted that full trial data has not been released yet, the company says that it will be published in a peer-reviewed journal soon. Due to the exceedingly optimistic findings of the Moderna coronavirus vaccine, the biotech company is filing for the United States and European emergency regulatory approval so that it can be recommended for widespread use.

Moderna is the third vaccine to show encouraging results during trials. Other being AstraZeneca and Pfizer vaccines. The positive results of vaccine trials are welcoming news for the world as the number of coronavirus cases is increasing rapidly across the globe and every nation is desperate to find a cure and/or preventive medicine for this deadly disease as soon as possible.

پاکستان تازہ ترین خبریں, پاکستان عنوانات

Similar News:آپ اس سے ملتی جلتی خبریں بھی پڑھ سکتے ہیں جو ہم نے دوسرے خبروں کے ذرائع سے جمع کی ہیں۔

Severe reaction to Moderna vaccine 'rare': US studySevere allergic reaction to Moderna's Covid-19 vaccine is
ذریعہ: 24NewsHD - 🏆 19. / 51 مزید پڑھ »

Russia says registers third coronavirus vaccineRussia was the first country to register a vaccine against Covid-19 in August The virus has mutated worthless vaccines
ذریعہ: DunyaNews - 🏆 1. / 83 مزید پڑھ »

Safety of covid vaccine is more important than price: Fawad ChThe first cabinet committee meeting for procurement of COVID-19 vaccine was held on Wednesday. It's mean he is going to buy expensive or going show in papers Safty 😂. Everyday jalsa where is safty 😂 Other countries started and u r still giving statements ... shame on you and your government.. what a incompetent people 🙄🙄🙄🙄
ذریعہ: DunyaNews - 🏆 1. / 83 مزید پڑھ »

China gives its first COVID-19 vaccine approval to SinopharmChina gives its first COVID-19 vaccine approval to Sinopharm
ذریعہ: DunyaNews - 🏆 1. / 83 مزید پڑھ »

China approves inhaled CanSino vaccine for clinical trialsChina's drug authority has approved for clinical trials an inhaled Covid-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a
ذریعہ: 24NewsHD - 🏆 19. / 51 مزید پڑھ »